129 related articles for article (PubMed ID: 36946146)
1. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D
J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146
[TBL] [Abstract][Full Text] [Related]
2. Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar.
Abushanab D; Atchan M; Elajez R; Elshafei M; Abdelbari A; Al Hail M; Abdulrouf PV; El-Kassem W; Ademi Z; Fadul A; Abdalla E; Diab MI; Al-Badriyeh D
PLoS One; 2023; 18(6):e0286419. PubMed ID: 37262042
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacists' interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis.
Yakti O; Al-Badriyeh D; Rijims M; Abdelaal M; Alsoukhni O; Al Hail M; Abdulrouf PV; El-Kassem W; Abounahia F; Kaddoura R; Abushanab D
J Pharm Policy Pract; 2024; 17(1):170-190. PubMed ID: 38236554
[TBL] [Abstract][Full Text] [Related]
4. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service.
Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN
J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815
[TBL] [Abstract][Full Text] [Related]
5. Impact of Clinical Pharmacist Interventions on Economic Outcomes in a Cardiology Setting in Qatar.
Al-Badriyeh D; Kaddoura R; AlMaraghi F; Homosy A; Hail MA; El-Kassem W; Rouf PVA; Fadul A; Mahfouz A; Alyafei SA; Abushanab D
Curr Probl Cardiol; 2023 Sep; 48(9):101838. PubMed ID: 37244514
[TBL] [Abstract][Full Text] [Related]
6. A cost avoidance study of critical care pharmacists' interventions in a tertiary institution in Singapore.
Chan LEJ; Soong JL; Lie SA
Am J Health Syst Pharm; 2023 Feb; 80(5):267-283. PubMed ID: 36371740
[TBL] [Abstract][Full Text] [Related]
7. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Economic Impact of Pharmacists' Intervention on Care of Pediatric Hematology and Oncology Patients.
Kim HJ; Lee S; Lee YJ; Kim S; Jo YH; Cho YS; An HY; Hong KT; Choi JY; Kang HJ; Shin HY; Lee JY
J Oncol Pharm Pract; 2023 Mar; 29(2):319-325. PubMed ID: 34931912
[TBL] [Abstract][Full Text] [Related]
9. Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy.
Lankford C; Dura J; Tran A; Lam SW; Naelitz B; Willner M; Geyer K
J Manag Care Spec Pharm; 2021 Mar; 27(3):379-384. PubMed ID: 33645240
[No Abstract] [Full Text] [Related]
10. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.
Saokaew S; Maphanta S; Thangsomboon P
Pharm Pract (Granada); 2009 Apr; 7(2):81-7. PubMed ID: 25152782
[TBL] [Abstract][Full Text] [Related]
11. Cost-benefit analysis of clinical pharmacist intervention in preventing adverse drug events in the general chronic diseases outpatients.
Al-Qudah RA; Al-Badriyeh D; Al-Ali FM; Altawalbeh SM; Basheti IA
J Eval Clin Pract; 2020 Feb; 26(1):115-124. PubMed ID: 31234234
[TBL] [Abstract][Full Text] [Related]
12. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
Muñoz-Pichuante D; Villa-Zapata L
J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
[TBL] [Abstract][Full Text] [Related]
13. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
Hamblin S; Rumbaugh K; Miller R
J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
[TBL] [Abstract][Full Text] [Related]
14. Cost savings and avoidance from clinical interventions.
Mutnick AH; Sterba KJ; Peroutka JA; Sloan NE; Beltz EA; Sorenson MK
Am J Health Syst Pharm; 1997 Feb; 54(4):392-6. PubMed ID: 9043561
[TBL] [Abstract][Full Text] [Related]
15. Implementation of the standardized process of Pharmacotherapeutic evaluation in inpatients and outpatients.
González A; Gutiérrez W; Fuenzalida T; Lizana F; Gutiérrez M; Severino N
Farm Hosp; 2023; 47(6):254-260. PubMed ID: 37198085
[TBL] [Abstract][Full Text] [Related]
16. [Translated article] Implementation of the standardized process of drug therapy evaluation in inpatients and outpatients.
González A; Gutiérrez W; Fuenzalida T; Lizana F; Gutiérrez M; Severino N
Farm Hosp; 2023; 47(6):T254-T260. PubMed ID: 37735005
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Economic Benefits of Pharmacist Involvement in a Community Hospital-Affiliated Patient-Centered Medical Home.
Tate ML; Hopper S; Bergeron SP
J Manag Care Spec Pharm; 2018 Feb; 24(2):160-164. PubMed ID: 29384022
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of clinical pharmacy service using integrated health system in tertiary care hospital.
Amir M; Zehra A; Munawar R; Gul W; Fatima T; Khan Y; Jaffery R; Babar ZU
Expert Rev Pharmacoecon Outcomes Res; 2024 Apr; 24(4):533-539. PubMed ID: 38362677
[TBL] [Abstract][Full Text] [Related]
19. Impact of pharmacist interventions on cost avoidance in an ambulatory cancer center.
Randolph LA; Walker CK; Nguyen AT; Zachariah SR
J Oncol Pharm Pract; 2018 Jan; 24(1):3-8. PubMed ID: 27682600
[TBL] [Abstract][Full Text] [Related]
20. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
Chuang LC; Sutton JD; Henderson GT
Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
